Literature DB >> 5694477

Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.

M Lane, J E Moore, H Levin, F E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5694477

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Methotrexate and 5-fluorouracil in the treatment of squamous and other carcinomas of the head and neck.

Authors:  D J Stewart; J A Maroun; C Cripps; V Young; G Laframboise; J Gerin-Lajoie
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  The variability of individual tolerance to methotrexate in cancer patients.

Authors:  H H Hansen; O S Selawry; J F Holland; C B McCall
Journal:  Br J Cancer       Date:  1971-06       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.